The curated database of hedge funds that publish investor letters. Research by geography, strategy, and schools of thought.
| # | Fund | Strategy | Style | Geography | AUM | Latest Letter |
|---|---|---|---|---|---|---|
As of Oct 28, 2026
Markel Group reported third-quarter 2026 operating revenues of $4.16 billion, representing a 6% increase over the prior-year period, while operating income reached $383 million. Adjusted operating income, which excludes public equity portfolio market value movements and intangible asset amortization, grew 14% to $707 million for the quarter. Consolidated financial results reflected disciplined underwriting execution and expanded investment yields, alongside continued capital return via $315 million in common share repurchases during the quarter and $685 million year to date. Long-term five-year metrics showed average adjusted operating income compounding at a 19% annual rate alongside a 10% reduction in shares outstanding. Performance across operating units was led by Markel Insurance, which delivered an adjusted underwriting gross premium volume increase of 9% for the quarter and a combined ratio of 92%, despite a three-point unfavorable impact from the exited Global Reinsurance division. Net investment income rose 5% to $233.6 million, bolstered by favorable fixed-income reinvestment yields. Meanwhile, the non-insurance operations demonstrated sound execution, as the Industrial segment generated 13% revenue growth, including 10% organic growth, and a 29% increase in adjusted operating income, while the Financial segment grew operating income by 30%. Capital allocation remained anchored in compounding intrinsic value per share through cycle-tested reinvestment and accretive buybacks. Markel continued to transition non-core operations, including completing the run-off of its Global Reinsurance renewal rights and moving the Hagerty business to a fronting model. Public equity portfolio fluctuations produced $281 million of net investment losses in the quarter, yet leadership reiterated its multi-decade commitment to patient long-term ownership of durable operating businesses with enduring pricing power.
Markel focuses on relentlessly compounding intrinsic value per share over the long term through disciplined specialty insurance underwriting, ownership of durable operating businesses with staying power, and patient capital allocation across market cycles.
Management intends to continue deploying capital where it creates the most long-term value, focusing on disciplined specialty underwriting, strong operating subsidiary returns, and patient reinvestment across cycles.
High Conviction Bullish
Market Conviction
Growth Outlook
Risk Appetite
Capital Deployment
Forward Guidance
Language Signal
Perceived Risk
Opportunity Density
Time Horizon
Top Conviction Themes
Key Catalysts
Every insight in this database connects to the original source. Read the actual thesis, see the actual concerns, and make your own call.
Buyside Digest has no business relationship, partnership, agency, sponsorship, endorsement, or affiliation with Markel Group or any other manager whose content appears on the Service, except where expressly stated. We do not receive Manager Content directly from managers in most cases; content is collected from publicly available sources. Managers have not necessarily reviewed, approved, authorized, or endorsed our display of their content, our editorial commentary, our metadata extraction, or our classifications. Use of a manager’s name is for accurate attribution and identification purposes only, under principles of nominative fair use.
Buyside Digest does not independently verify the regulatory status, registrations, licensing, qualifications, credentials, or professional standing of managers whose content appears on the Service. We do not represent that managers are properly registered with applicable regulatory bodies, that their content complies with applicable securities laws, or that their performance representations are accurate. Inclusion of a manager in our database is based on the publicly available nature of their content, not on our verification of their regulatory status or content compliance. Users are responsible for conducting their own due diligence on any manager.
Performance data, returns, assets under management (“AUM”), and similar figures displayed on this page are sourced from publicly available manager communications (including investor letters), public filings, or other third-party sources. Buyside Digest does not independently verify performance figures, calculate returns, or audit manager-reported data. Such figures: May be selectively reported by the manager; May use non-standard calculation methodologies; May not reflect fees, expenses, taxes, or other costs; May be inconsistent across reporting periods; May be outdated. Past performance is not indicative of future results. Performance figures should not be relied upon for investment decisions without independent verification. Users should request audited performance data directly from the manager and conduct their own due diligence.